Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to initially observe the safety and effectivity of RC18 in Participants with Neuromyelitis Optica Spectrum Disorders.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03330418
Study type Interventional
Source RemeGen Co., Ltd.
Contact Binghua Xiao
Phone 86-010-58076833
Email xiaosir522@163.com
Status Recruiting
Phase Phase 3
Start date January 29, 2018
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT02836327 - Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders N/A
Recruiting NCT04146285 - A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders Phase 1
Not yet recruiting NCT06068829 - Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders
Recruiting NCT05204459 - MS-ResearchBiomarkerS
Completed NCT03350633 - Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders Phase 2/Phase 3
Completed NCT04388072 - An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
Completed NCT05871658 - Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol N/A
Recruiting NCT02021825 - Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Phase 4
Recruiting NCT06249438 - A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy Phase 1
Not yet recruiting NCT06413654 - A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) Phase 2/Phase 3
Enrolling by invitation NCT04101058 - Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders
Enrolling by invitation NCT02809079 - Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients Phase 4
Recruiting NCT02889965 - The French Multiple Sclerosis Registry N/A
Completed NCT02850705 - The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)
Completed NCT04670770 - An Open Label Study of the Effects of SHR1459 in NMOSDs Patients Phase 2
Not yet recruiting NCT06212245 - A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders Phase 4
Completed NCT03062579 - A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD Phase 1/Phase 2
Recruiting NCT05730699 - Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE) Phase 3